Sponsor Profiles
Gold Sponsor
Abbott
For people living with chronic pain and movement disorders, Abbott’s neuromodulation portfolio of therapies help them move and feel better, allowing chronic pain patients to reduce or stabilize the long-term use of opioids and get back to living their lives.
We offer specialized devices for people suffering from chronic pain and movement disorders through solutions that deliver stimulation to the spinal cord, dorsal root ganglion and the brain.
• Our Proclaim series includes devices designed to deliver spinal cord stimulation (SCS) for the treatment of chronic pain, and dorsal root ganglion (DRG) stimulation for patients seeking relief from causalgia — nerve pain following surgery or injury — and complex regional pain syndrome (CRPS). The Proclaim DRG Neurostimulation System is the first and only neurostimulation device approved only for CRPS.
• Our Infinity Deep Brain Stimulation (DBS) system uses mild pulses of electricity to the brain, alleviating symptoms of Parkinson's disease and essential tremor.
AusCann
Our Vision: Revolutionising cannabinoid-based medicines through innovation.
AusCann is an Australian-based pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines within Australia and internationally.
Our key difference is the commitment to a rigorous pharmaceutical development program, focused on providing reliable, stable and standardised cannabinoid-based pharmaceutical products, whilst generating the clinical evidence to support market access.
We have built a strong team of experts and partners with both local and international connections. Our team has the right expertise across all aspects of the pharmaceutical value chain.
Our immediate focus is on providing healthcare professionals with solutions to optimise treatment outcomes for their patients. To do that, we developed an innovative formulation that is contained in a standardised capsule. AusCann’s capsules are designed to enable accurate dosing.
AusCann is dedicated to the provision of education for all healthcare professionals, to establish the Australian medical community’s trust and confidence in cannabinoid-based medicines.
Algostim
With over 20 years of experience in the field, our core focus is to deliver safe, reliable and minimally invasive neurostimulation solutions for the symptomatic relief and management of chronic peripheral neuropathic pain.
In Australia, we are excited to be partnered with Bioness Inc, to bring the fully implantable peripheral nerve stimulator, StimRouterÒ, to the Australian market. The StimRouter® lead has been designed to minimise migration and reduce recovery time and cost. The StimRouter® System accommodates patients with an active lifestyle, empowering them with complete control of their stimulator.
Bioness and the StimRouter® system were born from the Alfred Mann Foundation, with cochlear implants (Advanced Bionics), insulin delivery systems (Medtronic) and cardiac rhythm management (St Jude) being among the other technologies developed and sold over the years.
Algostim® is the sister company of UK based and ISO 13485 certified Algotec Research and Development.
Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For patients suffering from chronic pain, each patient’s needs are unique and personal. Boston Scientific is dedicated to working closely with both physicians and patients to develop meaningful, personalized solutions that can improve the quality of life for millions worldwide.
Mainstay Medical
Mainstay Medical is a medical device company focused on commercializing an implantable restorative neurostimulation system, ReActiv8®, for people with intractable Chronic Low Back Pain (CLBP) who are not indicated for spine surgery. Restorative Neurostimulation aims to relieve symptoms by restoring impaired neuromuscular control of the multifidus muscle which normally provides functional stability to the lumbar spine.
The Company is headquartered in Dublin, Ireland and has subsidiaries in the United States, Australia, Germany and the Netherlands. ReActiv8 received Therapeutic Goods Agency (TGA) approval for Australia, CE Mark for Europe and Food and Drug Administration (FDA) approval for the United States of America.
Medistar
Medistar is committed to enhancing the lives of patients through educating and supporting clinicians with technologies that improve efficiencies and outcomes.
Medistar supplies the innovative Nimbus Radio-Frequency Multi-tined Expandable Electrode from Stratus Medical, and the Clarius HD Wireless Ultrasound Scanners to medical specialists and clinics across Australia and New Zealand.
The Nimbus RF MEE changes the way that RF procedures are performed. Incorporating a novel design, the Nimbus RF electrode facilitates a simple “down-the-beam” approach to deliver a consistently larger treatment area and shorter procedures times.
Clarius Mobile Health was founded to empower every medical professional with accurate, easy to use and affordable imaging tools and miniaturizing high quality point-of-care ultrasound to offer a safe and cost-effective option for all clinicians in every specialty. Clarius Wireless HD Scanners incorporate advanced AI technologies to provide high quality images and utilise advanced Octal Beamforming technology, typically found in premium cart-based systems.
Nevro
Nevro is a global medical device company focused on providing innovative therapies that improve the quality of life of patients suffering from chronic pain. Nevro’s Senza® spinal cord stimulation system is an evidence-based neuromodulation platform developed for treating chronic pain and the only SCS system that delivers Nevro’s proprietary HF10TM therapy.Saluda Medical
Seqirus
Seqirus has public health protection at its core, reflecting the promise of our parent company - CSL Limited - which was founded in 1916 to save lives and protect the health of people. Together with our partners on the front line, we have served Australia’s healthcare needs for over a century. Today we develop, manufacture and source medicines that support the health and well-being of many thousands of people around the world. Seqirus operates Australia’s only local manufacturing facility for seasonal and pandemic influenza vaccine, and produces a range of unique medicines in the national interest including antivenoms and Q fever vaccine. Seqirus also in-licenses a broad range of paediatric and adult vaccines and specialty pharmaceutical products including Palexia®SR (tapentadol sustained release), Palexia® IR (tapentadol immediate release) and Versatis® (lidocaine [lignocaine]).Bronze Sponsor
Medtronic
Making healthcare better is our priority and we believe technology can play an even greater role in improving people’s lives. In addition to alleviating pain, restoring health, extending lives, we work in partnership with others to create seamless, more efficient care. Learn how we’re taking healthcare Further, Together at Medtronic.com.
Tilray
Tilray is dedicated to supporting healthcare professionals and patients with access to our GMP – certified medicinal cannabis products. We supply our products to government and hospital clients across Australia. We invite you to our virtual stand to discuss EASYSAS – an online visual guide to the TGA’s Special Access Scheme.
Conference Secretariat
DC Conference & Association Management
Suite 103, Level 1, 3-5 West Street
North Sydney NSW 2060
Australia
Contact Us
T: +61 2 9954 4400
E: pain2020@dcconferences.com.au
Follow us on Twitter and use #PAIN2020SYD